189
Participants
Start Date
May 31, 2014
Primary Completion Date
September 30, 2015
Study Completion Date
October 31, 2015
Febuxostat IR
Febuxostat IR over-encapsulated tablets
Febuxostat XR
Febuxostat over-encapsulated capsules
Febuxostat placebo
Febuxostat IR and XR placebo-matching capsules
Colchicine
Colchicine tablets
Naproxen
Naproxen tablets
Lansoprazole
Lansoprazole capsules
Riverside Clinical Research, Edgewater
Remesh C Gupta MD, Memphis
Central Kentucy Reseach Associates, Lexington
Benny Green MD PA Family Practice, Little Rock
COR Clinical Research LLC, Oklahoma City
Sun Research Institute, San Antonio
Briggs Clinical Research LLC, San Antonio
3rd Coast Research Associates, Corpus Christi
Long Beach Center for Clinical Research, Long Beach
Brigid Freyne MD, Murrieta
East West Medical Research Institute, Honolulu
Birmingham
Muscle Shoals
Phoenix
Little Rock
Bellflower
Escondido
Harbor City
Huntington Park
Irvine
Lomita
Long Beach
Los Angeles
Murrieta
Orange
Rancho Cucamonga
Redondo Beach
Sacramento
San Jose
San Ramon
Clearwater
Coral Gables
Coral Springs
Edgewater
Hialeah
Miami
Miami Beach
Miami Lakes
Orlando
Pembroke Pines
Plantation
Port Charlotte
Saint Cloud
Vero Beach
Atlanta
Dunwoody
East Point
Suwanee
Honolulu
Brownsburg
Manhattan
Wichita
Elizabethtown
Lexington
Paducah
Mandeville
Metairie
Fall River
Detroit
Kalamazoo
Hazelwood
Washington
Las Vegas
Albuquerque
Columbiana
Greensboro
Salisbury
Wilmington
Fargo
Franklin
Oklahoma City
Portland
Columbia
Greer
Old Point Station
Clarksville
Knoxville
Memphis
Austin
Bellaire
Corpus Christi
Nassau Bay
Plano
San Antonio
Bountiful
Newport News
Norfolk
Richmond
Virginia Beach
Lead Sponsor
Takeda
INDUSTRY